Rocket One Inc. SEC filings RKTO
Rocket One Inc. has 352 filings in SEC EDGAR's recent list, going back to Jul 14, 2017. Its latest annual report, Form ARS, was filed on Oct 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| EFFECT | Filing | Apr 19, 2024 | — |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2024 | — |
| EFFECT | Filing | Jun 16, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2023 | — |
| CORRESP | Letter to the SEC | Jun 15, 2023 | — |
| EFFECT | Filing | Jan 25, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2023 | — |
| D | Filing | Jan 4, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2023 | — |
| CORRESP | Letter to the SEC | Jan 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| DEFR14A | Definitive revised proxy statement | May 7, 2021 | — |
| EFFECT | Filing | Apr 5, 2021 | — |
| CORRESP | Letter to the SEC | Mar 30, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2021 | — |
| D | Filing | Mar 16, 2021 | — |
| EFFECT | Filing | Jan 15, 2021 | — |
| CORRESP | Letter to the SEC | Jan 13, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2021 | — |
| D | Filing | Jan 8, 2021 | — |
| EFFECT | Filing | May 6, 2020 | — |
| CORRESP | Letter to the SEC | May 5, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2020 | — |
| EFFECT | Filing | Mar 11, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2020 | — |
| EFFECT | Filing | Oct 25, 2019 | — |
| CORRESP | Letter to the SEC | Oct 23, 2019 | — |
| CORRESP | Letter to the SEC | Oct 23, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2019 | — |
| EFFECT | Filing | Sep 13, 2019 | — |
| CORRESP | Letter to the SEC | Sep 12, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2019 | — |
| D | Filing | Aug 21, 2019 | — |
| CT ORDER | Filing | Feb 15, 2019 | — |
| EFFECT | Filing | Feb 14, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| CERT | Filing | Feb 7, 2019 | — |
| CORRESP | Letter to the SEC | Feb 6, 2019 | — |
| CORRESP | Letter to the SEC | Feb 6, 2019 | — |
| 8-A12B | Filing | Feb 6, 2019 | — |
| CORRESP | Letter to the SEC | Feb 5, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2019 | — |
| CORRESP | Letter to the SEC | Feb 1, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2019 | — |
| CORRESP | Letter to the SEC | Dec 14, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2018 | — |
| CORRESP | Letter to the SEC | Oct 10, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2018 | — |
| DRS/A | Filing | Aug 14, 2018 | — |
| DRSLTR | Filing | Aug 13, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2018 | — |
| DRS | Filing | Jun 21, 2018 | — |
| D | Filing | Nov 7, 2017 | — |
| D | Filing | Jul 14, 2017 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RKTO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Hoboken, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1711786
- Former names
- Hoth Therapeutics, Inc. (until May 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.